Location: Home
  • search
  • go
  • Relate News
  • 11/1/2024Recent Executive Moves
  • 10/31/2024CStone Announces MHRA Approval of Sugemalimab for First-Line NSCLC Tre...
  • 10/31/2024China Investigation of Drug Firm Exec Deals Latest Blow to Foreign Bus...
  • 10/30/2024Eli Lilly's Weight-Loss Drug Mounjaro Set to Debut in Hong Kong
  • 10/30/2024China's BMI Negotiation Spotlight Record Number of Orphan Drugs
  • 10/30/2024AstraZeneca China President Under Investigation Amid Broader Scrutiny ...
  • 10/30/2024Zai Lab and BMS Move Toward KarXT Filing in China After Positive Phase...
  • 10/30/2024China Set to Achieve Full Drug and Medical Consumables Traceability by...
  • 10/29/2024SMEI: Chinese Terminal Drug Market Fell 1.9% in H1/2024 (with Annual M...
  • 10/29/2024Nine Pharma MNCs Grew Their Combined China Revenue at 12.5% CAGR betwe...
  • 10/29/2024GSK Acquires CMG1A46 from Chimagen Biosciences to Expand Immunology P...
  • 10/29/2024Innovative Drugs Lead the 2024 Health Insurance Price Negotiations in ...
  • 10/28/2024Akeso's Gumokimab Shows Exceptional Long-Term Efficacy in Phase 3 Psor...
  • 10/28/2024China Expands Contract Manufacturing for Biopharmaceuticals in New Pil...
  • 10/28/2024China Begins 2024 NRDL Negotiations with Key Focus on Innovation and P...
  • 10/25/2024China and Denmark Strengthen Collaboration in Pharmaceutical and Medic...
  • 10/25/2024Data Review: Chinese Drug Market 2016-2023
  • 10/25/2024Recent Executive Moves
  • 10/24/2024Hope Medicine Announces Positive Results from a Global Phase 2 Study o...
  • 10/24/2024Sinopharm and Chinese Vaccine Makers Slash Prices Amid Fierce Market C...
  • 10/24/2024NHSA to Initiate New Round of Negotiation for 2024 NRDL Listing
  • 10/24/2024Reinventing Your China Strategy: A Podcast Preview of the China Health...
  • 10/23/2024Guangzhou Aims to Establish Itself as a Global Biopharmaceutical Hub
  • 10/23/2024China Recovers CNY 16B in Misused BMI Funds
  • 10/22/2024Bristol Ends LaNova Partnership on Claudin18.2 ADC, Eyes Potential I-M...
  • 10/22/2024XellSmart RaisesCNY 100M+ in Series B1 Financing for iPS-Derived Cell ...
  • 10/21/2024Akeso Launches Phase 1/2 Trial for Novel Bispecific Antibody Combinati...
  • 10/21/2024BeiGene's Secures 14th Indication in China for Tislelizumab
  • 10/21/2024NMPA Issues the Pilot Plan for Staged Production of Biological Product...
  • 10/21/2024Changing Chinese Market Dynamics Hit Merck Where It Hurts (SCRIP Citel...
  • Page:17/356 Total number of articles:10656: [First][<<] [15] [16] [17] [18] [19] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group